MDS Virtual Congress 2021 Archives - Page 3 of 132

A French national multicentric prospective study of the 1-year impact of STN-DBS on speech in Parkinson’s disease: profile of progression and prognostic factors.

T. Ollivier, S. Pinto, R. Viard, G. Kuchcinski, G. Touzet, L. Defebvre, D. Devos, C. Moreau (Lille, France)
A Machine Learning Approach to VTA Prediction in DBS

B. Hoenes, G. Steinke (Valencia, USA)
A metadata-driven tool to determine the robustness of digital health technologies assessments for Parkinson’s disease leveraging the voice of the patient

S. Sardar, R. Bhatnagar, R. Badawy, J. Burton, V. Aggarwal, K. Romero, M. Minchik, M. Spott, D. Hill, J. Cosman, C. Lansdall, G. Stebbins, N. Zach, M. Frasier, T. Hastings, M. Javidnia, J. Duffen, H. Matthews, M. Lawton, D. Dexter, N. Ratcliffe, K. Fisher, L. Oliva, S. Jones, A. Dowling, M. Meinders, L. Evers, B. Bloem, J. Cedarbaum, M. Muller, D. Stephenson (Tucson, USA)
A Milestone-based approach to monitoring disease progression in Parkinson’s disease

M. Brumm, A. Siderowf, T. Simuni, C. Caspell-Garcia, L. Chahine, T. Foroud, V. Arnedo, A. Reimer, C. Tanner, K. Poston, D. Weintraub, S. Hutten, K. Kieburtz, K. Marek, C. Coffey (Iowa City, USA)
A National Data-Linkage Study of Incidence and Prevalence of Primary Dystonia

G. Bailey, A. Rawlings, W. Pickrell, K. Peall (Cardiff, United Kingdom)
A neurophysiological profile associated with impulse control disorders in Parkinson’s disease

E. Iglesias Camacho, JF. Martín-Rodríguez, I. Santiago García-Rayo, L. Garrote Espina, P. álvarez Toledo, P. Franco Rosado, S. Jesús, L. Muñoz Delgado, D. Macías-García, A. Adarmes-Gómez, F. Carrillo, P. Mir (Sevilla, Spain)
A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson’s disease

C. Fevga, Y. Park, E. Lohmann, A J. Kievit, G J. Breedveld, F. Ferraro, L. de Boer, R. van Minkelen, H. Hanagasi, A. Boon, W. Wang, G A. Petsko, Q Q. Hoang, M. Emre, V. Bonifati (Rotterdam, Netherlands)
A new fully implantable Adaptive Deep Brain Stimulation system tested for the first time in patients with Parkinson’s Disease

T. Mandat, R. Eleopra, M. Lanotte, L. Lopiano, M. Yanssen, Y. Temel, E. Pirola, P. Rampini (Warsaw, Poland)
A new mutation in the C-terminal domain of the YY1 gene associated with Gabriele-de Vries syndrome.

J. Gamez, M. Garcia-Hoyos, O. de Fabregues (Sant Just Desvern, Spain)
A New Phase of the Parkinson’s Outcomes Project Registry Study

A. Naito, C. Marras, J. Beck, R. Deleon, M. Neault, N. Dahodwala, T. Davis, M. Rafferty, A. Ramirez-Zamora, S. Luo (Miami, USA)